The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

Obstructive sleep apnea affects the quality of life of millions of people, but current solutions are not always well accepted ...

An existing drug has shown it can significantly improve the quality of sleep for those suffering from obstructive sleep apnea (OSA), so much so that many trial participants were able to hang up their ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

Commonly prescribed sleep medications such as zolpidem are not associated with a meaningful increase in the overall risk for ...

A popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found. Tirzepatide, the medicine found in the drug Zepbound and the obesity drug Mounjaro, reduced the ...

Intermezzo could help those who wake in the night, but some doctors cautious. April 4, 2012— -- Your eyes snap open, but the room is dark and the alarm clock reads 2 a.m. It's a frustrating but ...

Testing for a new sleep apnea drug has proven exceptionally successful. Not only has the drug allowed some patients to abandon their CPAP machines entirely, but it has also helped boost weight loss ...

A reduction in prescriptions of sleep drugs for older adults is associated with substantial health and economic benefits, according to an October study published in The Lancet Regional Health – ...

Millions of older Americans suffering from insomnia regularly use prescription sleep medications, despite the risk of serious side effects-such as falls, broken bones, cognitive impairment and ...

A new drug appears to reverse the fuzzy thinking caused by a lack of sleep. Studies in monkeys and people show that the drug restores the ability to perform complex mental tasks. The research is being ...

Among nearly 4.3 million pregnancies in a Medicaid database and a commercial insurance database, the adjusted pooled relative ...